Merge eClinical Announces New Mobile App


Applied Clinical Trials

Study Connect™ App Enables the Mobile Management of Randomization, Inventory Management and Unblinding in Clinical Trials

Study Connect™, a new mobile app from Merge eClinical, allow users of its eClinicalOS (eCOS) to perform a wide array of clinical trial management functions from their iOS-based mobile devices.

Seamlessly integrated with eCOS, Study Connect™enables researchers to: 

·       Manage randomization of subjects

·       Coordinate dispensing and inventory management

·       Unblind individual subjects, as circumstances warrant

·       Stay connected with real-time customized notifications

·       Monitor enrollment and establish milestone alerts

·       Share top-level statistics for each study with key stakeholders using the study dashboard

·       Expedite approval response times for critical study decisions such as patient study eligibility

·       Maintain security with the ability to set customized role-based permissions for individual studies.


Read the full release here. 

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.